Risk Factors and Tricuspid - Cardiovascular Update

Significant Tricuspid Regurgitation After Cardiovascular Implantable Electronic Device Implantation and the Impact on Long-term Prognosis

HeartRhythm

APRIL 2, 2025

Tricuspid regurgitation (TR) after implantation of cardiovascular implantable electronic devices (CIED) is a concern, possibly due to lead impingement or underlying cardiac abnormalities. While TR after CIED may worsen prognosis,1 data on its progression, risk factors, and impact on cardiac structure and function are limited.

Tricuspid

Tricuspid Risk Factors

Risk Factors and Long‐Term Outcomes of Tricuspid Regurgitation After Transcatheter Closure of Pediatric Perimembranous Ventricular Septal Defects

Journal of the American Heart Association

MARCH 7, 2025

BackgroundTranscatheter closure of perimembranous ventricular septal defects in children is a highly effective procedure, but it can result in tricuspid regurgitation (TR). TR was evaluated using echocardiography, and multivariate logistic regression was performed to identify independent risk factors of postprocedural TR.

Risk Factors

Risk Factors Tricuspid Pediatrics Outcomes

PO-03-174 PREDICTORS OF PERMANENT PACEMAKER PLACEMENT IN PATIENTS UNDERGOING TRICUSPID VALVE SURGERY-A RETROSPECTIVE COHORT STUDY OF THE NATIONAL INPATIENT SAMPLE

HeartRhythm

APRIL 30, 2024

Tricuspid valve surgery for isolated tricuspid valve disease is becoming increasingly common. Incidence and risk factors of this complication are not well established. These patients often need permanent pacemaker (PPM) post-surgery.

Tricuspid

Tricuspid Pacemaker Inpatient Risk Factors

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

A meta‐analysis of the distance between lead‐implanted site and tricuspid valve annulus with postoperative tricuspid regurgitation deterioration in patients with left bundle branch area pacing

Journal of Cardiovascular Electrophysiology

NOVEMBER 5, 2024

Abstract Tricuspid regurgitation (TR) is a known complication of cardiac implantable electrical devices (CIEDs), with prevalences ranging from 10% to as high as 30%. A shorter lead-TA-distance was an independent risk factor for TR deterioration in individuals with post-LBBAP implantation.

Tricuspid

Tricuspid Risk Factors

Right ventricular function and anemia in heart failure with preserved ejection fraction

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

The level of hemoglobin (Hb) had a weak negative linear correlation with NT-pro-BNP (log-transform, r = 0.30, P < 0.0001) and a positively correlation with the tricuspid annular plane systolic excursion (TAPSE)/pulmonary arterial systolic pressure (PASP) ratio (r = 0.44, P < 0.0001).

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure Tricuspid Atrial Fibrillation

Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

Journal of the American Heart Association

JANUARY 9, 2024

Herein, we provide an overview of the current knowledge on the pathophysiology and risk factors for AF in adult congenital heart disease, with a special focus on the existing challenges in AF ablation. Emerging imaging modalities and ablation techniques might have a role to play.

Congenital Heart Disease

Congenital Heart Disease Atrial Fibrillation Congenital Heart Disease

Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

European Journal of Heart Failure

FEBRUARY 26, 2025

This clinical consensus statement provides a comprehensive overview of low BP in HFrEF, including its definition, risk factors, and effects of HF therapies on BP. Low blood pressure with major or mild symptoms. **SBP SBP <80mmHg or symptomatic low BP or asymptomatic low BP.

Blood Pressure

Blood Pressure Heart Failure Aortic valve TAVR

Burden of Valvular Heart Diseases in a Racially and Ethnically Diverse Population: The Bronx‐Valve Registry

Journal of the American Heart Association

JANUARY 16, 2025

In people aged 75 years, tricuspid and mitral regurgitation were the most prevalent VHD (21.1% Appropriate resources and strategies need to be implemented to minimize racial and ethnic disparities and promote equity in VHD diagnosis and cardiovascular risk factor management.RegistrationURL:[link] Unique Identifier: NCT05453526.

Heart Disease

Heart Disease Tricuspid Bicuspid/Mitral Echocardiogram

Echocardiographic Profiling Predicts Clinical Outcomes After Mitral Transcatheter Edge?to?Edge Repair

Journal of the American Heart Association

FEBRUARY 23, 2024

BackgroundPrior studies investigating the impact of residual mitral regurgitation (MR), tricuspid regurgitation (TR), and elevated predischarge transmitral mean pressure gradient (TMPG) on outcomes after mitral transcatheter edge‐to‐edge repair (TEER) have assessed each parameter in isolation. Overall, mean age was 76.7±10.6

Bicuspid/Mitral

Bicuspid/Mitral Outcomes Risk Factors Tricuspid

Incidence, Risk Factors, and Outcomes Associated With Permanent Pacemaker Implantation Following Tricuspid Valve Surgery

Journal of the American Heart Association

JANUARY 31, 2024

BackgroundData regarding permanent pacemaker (PPM) implantation following tricuspid valve surgery (TVS) are limited. We sought to evaluate its incidence, risk factors, and outcomes.Methods and ResultsMedicare beneficiaries who underwent TVS from 2013 to 2020 were identified. 1.49],P=0.04). 1.49],P=0.04). 4.75],P<0.0001).

Risk Factors

Risk Factors Tricuspid Pacemaker Outcomes

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Part 2: Empirical Studies in Cardiac Surgery; Risk Model Recommendations The Annals of Thoracic Surgery January 2022 David Shahian Social Risk Factors in Society of Thoracic Surgeons Risk Models.

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Comprehensive strain assessment and mortality after acute myocardial infarction: a retrospective observational study based on the Essen Coronary Artery Disease registry

Heart BMJ

NOVEMBER 25, 2024

Adding LV ejection fraction, tricuspid annular plane systolic excursion (TAPSE) or LA volume index to these models did not alter the association of strain measures of the LV (1.41 (1.06–1.89), p=0.02), RV (1.48 (1.03–2.13), p=0.04) or LA (0.61 (0.49–0.76), p<0.001).

Myocardial Infarction

Myocardial Infarction Coronary Artery Disease Blood Pressure Tricuspid

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Clinical and echocardiographic parameters associated with outcomes in patients with moderate secondary mitral regurgitation

Heart BMJ

DECEMBER 13, 2024

However, data focusing specifically on moderate SMR and associated risk factors are lacking. Background Significant secondary mitral regurgitation (SMR) is known to be associated with worse prognosis. After matching, NYHA class and SMR aetiology remained associated with both outcomes (for both: log rank p<0.050).

Bicuspid/Mitral

Bicuspid/Mitral Outcomes Pulmonary Tricuspid

Right atrial strain in Anderson–Fabry disease

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

MethodsWe prospectively enrolled patients with FD and controls matched for age, sex, and cardiovascular risk factors. No differences were found for tricuspid annular plane systolic excursion (p=0.073) and RV fractional area change (p=0.461), while RV systolic Tissue Doppler velocity was reduced in patients with FD (p=0.041).

Tricuspid

Tricuspid Risk Factors Research

Significant Tricuspid Regurgitation After Cardiovascular Implantable Electronic Device Implantation and the Impact on Long-term Prognosis

Risk Factors and Long‐Term Outcomes of Tricuspid Regurgitation After Transcatheter Closure of Pediatric Perimembranous Ventricular Septal Defects

PO-03-174 PREDICTORS OF PERMANENT PACEMAKER PLACEMENT IN PATIENTS UNDERGOING TRICUSPID VALVE SURGERY-A RETROSPECTIVE COHORT STUDY OF THE NATIONAL INPATIENT SAMPLE

Webinars

A meta‐analysis of the distance between lead‐implanted site and tricuspid valve annulus with postoperative tricuspid regurgitation deterioration in patients with left bundle branch area pacing

Right ventricular function and anemia in heart failure with preserved ejection fraction

Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

Burden of Valvular Heart Diseases in a Racially and Ethnically Diverse Population: The Bronx‐Valve Registry

Echocardiographic Profiling Predicts Clinical Outcomes After Mitral Transcatheter Edge?to?Edge Repair

Incidence, Risk Factors, and Outcomes Associated With Permanent Pacemaker Implantation Following Tricuspid Valve Surgery

Published Research

Comprehensive strain assessment and mortality after acute myocardial infarction: a retrospective observational study based on the Essen Coronary Artery Disease registry

Published Research

Clinical and echocardiographic parameters associated with outcomes in patients with moderate secondary mitral regurgitation

Right atrial strain in Anderson–Fabry disease

Stay Connected